HAMBURG, Germany and WILMINGTON, N.C., March 12, 2015 /PRNewswire/ -- bioskin® and Modoc Research Services, Inc.® today announced a strategic alliance for dermatological drug and device development services. This alliance will leverage the experience and expertise of both companies to provide an exceptional level of scientific and regulatory advice coupled with the clinical operational support needed for the conduct of global dermatological studies.
bioskin® is also pleased to announce the opening of its North American headquarters location in Wilmington, NC. Modoc Research, currently based in Wilmington, NC, will join bioskin® in their new joint headquarters facility located in the growing Mayfaire business district of Wilmington. The opening of the new office will bring increased access to a hands-on team of clinical research professionals to support their development programs with services ranging from management of single trials to the coordination of entire development programs.
"The opening of the Wilmington office is an important strategic move for bioskin®. With this office, our expanded clinical operations team will have greater access to our North American clients and study sites," said Walter Wigger-Alberti, MD, CEO and Managing Director of bioskin®.
"We are delighted to be working with bioskin®," said Julie Orr, President and CEO of Modoc Research. "Modoc and bioskin® share a common vision in their approach to clinical research. Our combined resources will provide our clients with the highest level of expertise, experience and commitment toward successful development of new therapies in dermatology and other related indications."
The alliance between bioskin® and Modoc Research will open new global opportunities for both companies.
"The Wilmington area is a growing cluster of clinical research companies," said Betsy Hughes-Formella, Executive Director of Business Development of bioskin®. "Having a strong pool of talent to draw from the area will serve us well as we continue to grow our North American business."
bioskin® is a leading full-service global contract research organization specializing in dermatology and related indications. bioskin® offers strategic planning and regulatory support for global dermatological product development as well as all core operational services for management of Phase I-IV clinical trials and medical device trials. Founded in 1992, bioskin® is headquartered in Hamburg, Germany. For more information visit: www.bioskincro.com.
About Modoc Research Services, Inc.®
Modoc Research is a niche clinical research organization providing clinical operational support for early phase clinical drug development across multiple therapeutic areas. Modoc offers services in clinical trial implementation, project management, clinical monitoring/auditing and medical writing. Founded in 2006, Modoc Research is headquartered in Wilmington, NC. For more information visit: www.modocresearch.com.
bioskin® and Modoc Research will be attending the AAD 73rd Annual Meeting (March 20 – 23, 2015) in San Francisco, CA and the DIA 51st Annual Meeting (June 14 – 17, 2015) in Washington, DC. To schedule a meeting, please contact [email protected] or [email protected].